Why the study?
Does the CRP 1059G/C gene polymorphism influence plasma CRP levels and the risk of acute myocardial infarction in Egyptian patients?
Does the CRP 1059G/C gene polymorphism influence plasma CRP levels and the risk of acute myocardial infarction in Egyptian patients?
The CRP 1059G/C gene polymorphism influences plasma CRP levels but is not associated with the risk of acute myocardial infarction in Egyptian patients.
GG genotype raises CRP levels without AMI association in Egyptians; leaves open polymorphism's role in infarction susceptibility.
AIMS: High-sensitivity C-reactive protein (hs-CRP) is an inflammatory marker, predicting the occurrence of acute myocardial infarction (AMI). Genetic predisposition to high baseline CRP might account for a high risk of heart diseases. Our study aimed at investigating an association of CRP 1059G/C gene polymorphism with plasma CRP levels and AMI in Egyptian patients. METHODS: Genotypes of 150 patients with AMI and 150 healthy sex and age-matched controls were analyzed using PCR-restriction fragment length polymorphism methods. hs-CRP concentrations were assessed. RESULTS: There was no significant association between CRP 1095G/C polymorphism and AMI. However, individuals with GG genotype had significantly higher plasma CRP concentration than those with GC and CC genotypes, in both controls (3.82 ± 1.03 vs. 2.34 ± 0.7; P = 0.001) and patients with AMI (8.39 ± 2.6 vs. 6.67 ± 2.4; P = 0.005). CONCLUSION: Our results revealed that CRP 1059G/C gene variation influences plasma CRP levels. Conversely, this polymorphism was not associated with the risk for AMI.
No takes yet. Share an insight, caveat, or question.
Ghattas et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: